Medicare’s drug pricing negotiations — the first of their kind in the United States, passed under President Joe Biden — face ...

SEC sues Elon Musk over Twitter purchase, Microsoft says businesses should get quantum ready in 2025, and more news to start ...

Also in today’s edition: ‘no-show’ international student data and significant progress in Israel-Hamas ceasefire talks ...

On its way out the door, the Biden administration is proposing that Medicare and Medicaid cover Ozempic and other GLP-1 drugs ...

The history of breakthrough weight loss medicines is riddled with tragic results. Based on the histories of phen-fen and ...

(Reuters) -Weight-loss drug developer Metsera, backed by ARCH Venture Partners, revealed a wider loss in its paperwork for a ...

Canadian public and private insurers have balked at covering certain medication for weight-loss, but that might change as the ...

“Nothing else is even close.” Musk first revealed he had shed pounds using a weight-loss drug in October 2022. When about his “secret” to getting a “ripped” physique quickly, the ...

Metsera reports $156.26 million loss in first nine months of 2024 Proceeds from IPO to fund MET-097i clinical trials Weight ... New York City-based biotech firm is developing injectable and oral ...

For a long time, dieting and exercise were the only realistic options for many people who wanted to lose weight, but recent ...